Evidence map›Paper›PMID 29794131›Full record

ArticleThe European respiratory journal2018

Multi-omic molecular profiling of lung cancer in COPD.

Brian J Sandri, Adam Kaplan, Shane W Hodgson, Mark Peterson, Svetlana Avdulov, LeeAnn Higgins, Todd Markowski, Ping Yang, Andrew H Limper, Timothy J Griffin and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in The European respiratory journal, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 32 citations in OpenAlex.

  1. Integrative Analysis of Multimodal Omics Data.Annual review of statistics and its application · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Observational
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. sJIVE: Supervised Joint and Individual Variation Explained.Computational statistics & data analysis · 2022
    Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. SFPQ Promotes Lung Cancer MalignancyFrontiers in oncology · 2022
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 1 country.

Brian J SandriDivision of Pulmonary, Allergy, Critical Care, and Sleep Medicine, Dept of Medicine, University of Minnesota Medical School, Minneapolis, MN, USA.
Adam KaplanDivision of Biostatistics, School of Public Health, University of Minnesota, Minneapolis, MN, USA.
Shane W HodgsonPulmonary, Allergy, Critical Care, and Sleep Medicine, Veterans Affairs Medical Center, Minneapolis, MN, USA.
Mark PetersonDivision of Pulmonary, Allergy, Critical Care, and Sleep Medicine, Dept of Medicine, University of Minnesota Medical School, Minneapolis, MN, USA.
Svetlana AvdulovDivision of Pulmonary, Allergy, Critical Care, and Sleep Medicine, Dept of Medicine, University of Minnesota Medical School, Minneapolis, MN, USA.
LeeAnn HigginsDept of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, Minneapolis, MN, USA.
Todd MarkowskiDept of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, Minneapolis, MN, USA.
Ping YangDivision of Epidemiology, Mayo Clinic, Rochester, MN, USA.
Andrew H LimperDivision of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN, USA.
Timothy J GriffinDept of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, Minneapolis, MN, USA.
Peter BittermanDivision of Pulmonary, Allergy, Critical Care, and Sleep Medicine, Dept of Medicine, University of Minnesota Medical School, Minneapolis, MN, USA.
Eric F LockDivision of Biostatistics, School of Public Health, University of Minnesota, Minneapolis, MN, USA.
Chris H WendtDivision of Pulmonary, Allergy, Critical Care, and Sleep Medicine, Dept of Medicine, University of Minnesota Medical School, Minneapolis, MN, USA.
University of Minnesota · USUniversity of Minnesota Medical Center · USVeterans Health Administration · USMayo Clinic · USMayo Clinic in Arizona · US

Funding

University of Minnesota Clinical and Translational Science Institute (UMN CTSI)UL1TR000114 · NCATS · UNIVERSITY OF MINNESOTA · PI BLAZAR, BRUCE R · 2012 to 2015
$35.0M
University of Minnesota Clinical and Translational Science Institute (UMN CTSI)KL2TR000113 · NCATS · UNIVERSITY OF MINNESOTA · PI BLAZAR, BRUCE R · 2012 to 2015
$5.4M
Common Pathogenetic Mechanisms of Lung Cancer and COPDR01HL107612 · NHLBI · UNIVERSITY OF MINNESOTA · PI WENDT, CHRIS H, YANG, PING · 2011 to 2014
$2.8M
NCATS NIH HHS KL2 TR000113NCATS NIH HHS UL1 TR000114NHLBI NIH HHS R01 HL107612
6 · The paper itself

Abstract

Chronic obstructive pulmonary disease (COPD) is a known risk factor for developing lung cancer but the underlying mechanisms remain unknown. We hypothesise that the COPD stroma contains molecular mechanisms supporting tumourigenesis.We conducted an unbiased multi-omic analysis to identify gene expression patterns that distinguish COPD stroma in patients with or without lung cancer. We obtained lung tissue from patients with COPD and lung cancer (tumour and adjacent non-malignant tissue) and those with COPD without lung cancer for profiling of proteomic and mRNA (both cytoplasmic and polyribosomal). We used the Joint and Individual Variation Explained (JIVE) method to integrate and analyse across the three datasets.JIVE identified eight latent patterns that robustly distinguished and separated the three groups of tissue samples (tumour, adjacent and control). Predictive variables that associated with the tumour, compared to adjacent stroma, were mainly represented in the transcriptomic data, whereas predictive variables associated with adjacent tissue, compared to controls, were represented at the translatomic level. Pathway analysis revealed extracellular matrix and phosphatidylinositol-4,5-bisphosphate 3-kinase-protein kinase B signalling pathways as important signals in the tumour adjacent stroma.The multi-omic approach distinguishes tumour adjacent stroma in lung cancer and reveals two stromal expression patterns associated with cancer.

Indexed as

Signal TransductionAgedCase-Control StudiesFemaleGene Expression ProfilingGenetic Predisposition to DiseaseHumansLogistic ModelsLung NeoplasmsMaleMiddle AgedProteomePulmonary Disease, Chronic ObstructiveRNA, MessengerTranscriptomeProteomeRNA, Messenger

Identifiers

PMID29794131
PMCPMC6618293
OpenAlexW2804304830

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.